Search

everythinglearnresearchcommunity

for

Search:↓

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Melatonin improved mental health and metabolism in women with PCOS.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Finasteride affects SRD5A2 gene pattern, possibly causing lasting side effects.

Hair follicle sampling is a feasible method to measure FMRP and FMR1 mRNA levels in children.

Different treatments for PCOS focus on the specific symptoms, with weight loss and lifestyle changes being important.

Finasteride use may lead to less alcohol consumption in men with lasting sexual side effects.

New tools show that in fish, NPY increases feeding and somatostatin decreases it.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Women with PCOS have a higher chance of experiencing depression, anxiety, and sleep disorders.

The 2018 ISPAN Meeting emphasized hands-on learning, patient safety, and professional growth in medical aesthetics and reconstructive practices.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Platelet-rich plasma injections significantly improved hair regrowth and thickness in patients with hair loss.

Women with PCOS have higher levels of a certain growth factor, which can be reduced by taking metformin.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

Aldactone effectively reduces hair thickness in women with excessive hair growth, both alone and with other treatments.

PRP injections safely increase hair density and thickness in androgenetic alopecia.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Stress hormone corticosterone blocks a growth factor to slow down hair stem cell activity and hair growth.